Speakers

Hans Preusting

Co-Founder • DegenRx B.V

Hans Preusting has over 30 years of experience in the Life Science sector and previously served as Chief Business Officer and interim COO of uniQure. He is co-founder of two biotech start-up companies. One of them is DegenRx B.V., which was built based on his gene therapy experience at his time at uniQure. He holds two patents and has published over 20 scientific articles. His expertise is focused on business development, product development and manufacturing. He earned a PhD in biochemistry from the University of Groningen and an MBA from Rotterdam School of Management, The Netherlands. 

Also speaking

Åse Rosenqvist

Nordic Business Unit Lead Cell Therapy • Janssen

Angela Vollstedt

Global Director, Cell & Gene Therapies Portfolio Management • Novartis

Rolf Hemminga

Vice President Global Sales & Marketing Life Sciences • Emerson Automation Solutions

Event Info

Image

Sample Attendee List – 2024

Download and explore the 2024 Floorplan for Advanced Therapies Europe here.
Image

Enquire to Sponsor/Exhibit

Take a look at the sample attendee list for Advanced Therapies Europe 2024 here.